Cargando…

Will vaccination refusal prolong the war on SARS-CoV-2?

INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that appeared in Wuhan, China in January 2020 and caused a global pandemic drastically changing everyday life. Currently, there are vaccine candidates in clinical trials and development, so it is only a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcec, Robert, Majta, Matea, Likic, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016907/ https://www.ncbi.nlm.nih.gov/pubmed/33115909 http://dx.doi.org/10.1136/postgradmedj-2020-138903

Ejemplares similares

Commentary on ‘Will vaccination refusal prolong the war on SARS-CoV-2?’
por: Welsby, Philip D
Publicado: (2020)

Could fluvoxamine keep COVID-19 patients out of hospitals and intensive care units?
por: Marčec, Robert, et al.
Publicado: (2021)

Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?
por: Marcec, Robert, et al.
Publicado: (2022)

The relationship between vaccine acceptance and COVID-19 mortality in Europe: A Cross-Country analysis of public opinion and Epidemiological data
por: Brnic, Stjepan, et al.
Publicado: (2023)

SARS-CoV-2 vaccination in liver transplant recipients: factors affecting immune response and refusal to vaccine
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2022)

Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?
por: Marcec, Robert, et al.
Publicado: (2023)

A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference
por: Marcec, Robert, et al.
Publicado: (2022)

The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response
por: Migo, William, et al.
Publicado: (2021)

Near-Complete SARS-CoV-2 Seroprevalence among Rural and Urban Kenyans despite Significant Vaccine Hesitancy and Refusal
por: Nasimiyu, Carolyne, et al.
Publicado: (2022)

The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: “Vaccination Refusal Could Prolong the War of This Pandemic” – A Systematic Review
por: Wake, Addisu Dabi
Publicado: (2021)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Prolonged Infectivity of SARS-CoV-2 in Fomites
por: Pastorino, Boris, et al.
Publicado: (2020)

Kleinkind mit Enzephalitis - war es SARS-CoV-2?
por: Hoppen, Thomas, et al.
Publicado: (2022)

Refuse and the ‘Risk Society’: The Political Ecology of Risk in Inter-war Britain
por: Cooper, Timothy, et al.
Publicado: (2013)

The war against the SARS-CoV2 infection: Is it better to fight or mitigate it?
por: Dal Moro, Fabrizio, et al.
Publicado: (2020)

Pathologising ‘Refusal’: Prison, Health and Conscientious Objectors during the First World War
por: Hodgson, Max
Publicado: (2022)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids
por: Sun, Jiufeng, et al.
Publicado: (2020)

Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient
por: Nakajima, Yukiko, et al.
Publicado: (2021)

Tacrolimus: Prolonged shedding of SARS-CoV-2: case report
Publicado: (2021)

Prolonged SARS-CoV2 Viral Shedding in an Elderly Patient
por: Jariwal, Roopam, et al.
Publicado: (2021)

Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit
por: Kishimoto-Urata, Megumi, et al.
Publicado: (2022)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Modular nanoarray vaccine for SARS-CoV-2
por: Zagorski, Karen, et al.
Publicado: (2022)

Listening to vaccine refusers
por: Kärki, Kaisa
Publicado: (2021)

Tackling vaccine refusal
por: Gordijn, Bert, et al.
Publicado: (2022)

Vaccine hesitancy - vaccine refusal
por: Gür, Emel
Publicado: (2019)

Methotrexate/methylprednisolone/prednisone: Prolonged SARS-CoV-2 infection and masking of the symptoms of SARS-CoV-2 infection: case report
Publicado: (2020)

Would New SARS-CoV-2 Variants Change the War against COVID-19?
por: Redwan, Elrashdy M., et al.
Publicado: (2022)

Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children
por: Ricciardi, Alessandra, et al.
Publicado: (2022)

Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis
por: Farré, Núria, et al.
Publicado: (2020)

Ciclesonide/iguratimod: Prolonged presence of SARS-CoV-2: case report
Publicado: (2020)

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples
por: Wu, Yongjian, et al.
Publicado: (2020)

Is the oral cavity a reservoir for prolonged SARS-CoV-2 shedding?
por: Troeltzsch, Matthias, et al.
Publicado: (2021)

Prolonged PCR positivity in elderly patients infected with SARS-CoV-2
por: Howard-Jones, Annaleise R., et al.
Publicado: (2021)

Intra-host evolution during SARS-CoV-2 prolonged infection
por: Voloch, Carolina M, et al.
Publicado: (2021)

Prolonged detection of SARS-CoV-2 RNA in chronic haemodialysis patients
por: Ribitsch, Werner, et al.
Publicado: (2021)

Cyclophosphamide/doxorubicin: Prolongation of SARS-CoV-2 infection: case report
Publicado: (2021)

Prolonged viral shedding of SARS-CoV-2 in patients with acute leukemia
por: Altamirano-Molina, Milagros, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kkskm6248ihvt62lfuos2qlcb9